Announcements Trials
Browse Landscape

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 1387Neoplasms 1164Colorectal Neoplasms 624Lung Neoplasms 559Prostatic Neoplasms 538Carcinoma, Non-Small-Cell Lung 443Carcinoma, Hepatocellular 296Stomach Neoplasms 272Pancreatic Neoplasms 270Colonic Neoplasms 264Ovarian Neoplasms 230Head and Neck Neoplasms 228Rectal Neoplasms 221Melanoma 215Multiple Myeloma 202Uterine Cervical Neoplasms 198Lymphoma 195Leukemia 193Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Neoplasm Metastasis 178Carcinoma, Renal Cell 177Esophageal Neoplasms 173Brain Neoplasms 173Leukemia, Myeloid, Acute 158Urinary Bladder Neoplasms 138Recurrence 123Polycystic Ovary Syndrome 122Liver Neoplasms 118Hematologic Neoplasms 117Endometrial Neoplasms 107

Interventions

Observation 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Observational × Advanced Ovarian Cancer × Clear all
NCT05775549 2024-09-20

FLAME

AstraZeneca

Completed
24 enrolled
Gynecologic

Advanced Ovarian Cancer

NCT04135521 2020-06-29

Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer

Far Eastern Memorial Hospital

Completed
50 enrolled
Gynecologic

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡